Search research articles
Contact Us
Filters
Showing results (31-40 of 90) with videos related to
Page
of 9
Sort By:
Diagnostic Microbiology and Infectious Disease
|
April 25, 2006
Ceftobiprole medocaril (BAL5788) treatment of experimental Haemophilus influenzae, Enterobacter cloacae, and Klebsiella pneumoniae murine pneumonia
Mark S Rouse, Melanie M Hein, Paloma Anguita-Alonso, et al.
Diagnostic Microbiology and Infectious Disease
|
April 29, 1998
In vitro activity of LY333328 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and penicillin-resistant Streptococcus pneumoniae
R Patel, M S Rouse, K E Piper, et al.
The Journal of Infectious Diseases
|
August 10, 2006
Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model
Jennifer A Shuford, Mark S Rouse, Kerryl E Piper, et al.
Antimicrobial Agents and Chemotherapy
|
June 10, 2009
Anidulafungin treatment of candidal central nervous system infection in a murine model
Cheol-In Kang, Mark S Rouse, Jayawant N Mandrekar, et al.
Antimicrobial Agents and Chemotherapy
|
May 27, 2005
Selection of cross-resistance following exposure of Pseudomonas aeruginosa clinical isolates to ciprofloxacin or cefepime
Samer A Alyaseen, Kerryl E Piper, Mark S Rouse, et al.
Antimicrobial Agents and Chemotherapy
|
March 30, 2006
Garenoxacin treatment of experimental endocarditis caused by viridans group streptococci
Paloma Anguita-Alonso, Mark S Rouse, Kerryl E Piper, et al.
Antimicrobial Agents and Chemotherapy
|
February 27, 1999
Ketolide treatment of Haemophilus influenzae experimental pneumonia
K E Piper, M S Rouse, J M Steckelberg, et al.
Antimicrobial Agents and Chemotherapy
|
September 1, 1994
Failure of time-kill synergy studies using subinhibitory antimicrobial concentrations to predict in vivo antagonism of cephalosporin-rifampin combinations against Staphylococcus aureus
C M Brandt, M S Rouse, B M Tallan, et al.
The Journal of Antimicrobial Chemotherapy
|
October 1, 1986
Activity of penicillin combined with an aminoglycoside against group B streptococci in vitro and in experimental endocarditis
R J Backes, M S Rouse, N K Henry, et al.
European Journal of Clinical Microbiology
|
June 1, 1987
Comparative in vitro activity of the new penem CGP 31608
M E McConnell, S Sarria-Cepeda, M S Rouse, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 90) with videos related to
Sort By:
Page
of 9
Diagnostic Microbiology and Infectious Disease
|
April 25, 2006
Ceftobiprole medocaril (BAL5788) treatment of experimental Haemophilus influenzae, Enterobacter cloacae, and Klebsiella pneumoniae murine pneumonia
Mark S Rouse, Melanie M Hein, Paloma Anguita-Alonso, et al.
Diagnostic Microbiology and Infectious Disease
|
April 29, 1998
In vitro activity of LY333328 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and penicillin-resistant Streptococcus pneumoniae
R Patel, M S Rouse, K E Piper, et al.
The Journal of Infectious Diseases
|
August 10, 2006
Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model
Jennifer A Shuford, Mark S Rouse, Kerryl E Piper, et al.
Antimicrobial Agents and Chemotherapy
|
June 10, 2009
Anidulafungin treatment of candidal central nervous system infection in a murine model
Cheol-In Kang, Mark S Rouse, Jayawant N Mandrekar, et al.
Antimicrobial Agents and Chemotherapy
|
May 27, 2005
Selection of cross-resistance following exposure of Pseudomonas aeruginosa clinical isolates to ciprofloxacin or cefepime
Samer A Alyaseen, Kerryl E Piper, Mark S Rouse, et al.
Antimicrobial Agents and Chemotherapy
|
March 30, 2006
Garenoxacin treatment of experimental endocarditis caused by viridans group streptococci
Paloma Anguita-Alonso, Mark S Rouse, Kerryl E Piper, et al.
Antimicrobial Agents and Chemotherapy
|
February 27, 1999
Ketolide treatment of Haemophilus influenzae experimental pneumonia
K E Piper, M S Rouse, J M Steckelberg, et al.
Antimicrobial Agents and Chemotherapy
|
September 1, 1994
Failure of time-kill synergy studies using subinhibitory antimicrobial concentrations to predict in vivo antagonism of cephalosporin-rifampin combinations against Staphylococcus aureus
C M Brandt, M S Rouse, B M Tallan, et al.
The Journal of Antimicrobial Chemotherapy
|
October 1, 1986
Activity of penicillin combined with an aminoglycoside against group B streptococci in vitro and in experimental endocarditis
R J Backes, M S Rouse, N K Henry, et al.
European Journal of Clinical Microbiology
|
June 1, 1987
Comparative in vitro activity of the new penem CGP 31608
M E McConnell, S Sarria-Cepeda, M S Rouse, et al.
Page
of 9